Quantics Biostatistics

Quantics is a specialist consultancy offering biostatistical and biomathematical expertise to all sectors within the life science industry. We focus on the maths so you can focus on the science! Our purpose is to expedite project delivery by providing comprehensive and concise data analysis and interpretation, so that you can swiftly move forward with your product development. As experts in biostatistics, Quantics provide services in the following core areas: Bioanalytics for biologics - projects include biosimilars, mAbs, immunotherapies, cell and gene therapies, vaccine development: • Bioassay and ELISA development, validation, GMP release/stability testing • Relative potency, parallelism, model choice, suitability criteria • Assay trending and monitoring • Method bridging • Correlates of protection Pre-clinical / Clinical Phase I - IV / Post-Market Clinical Follow Up - trials include pharmaceutical and medical devices: • PK/PD studies • Study design • Sample size calculations • Independent protocol review • SAS programming • Interim analysis Health Technology Assessment (HTA): • Network meta-analysis (direct, indirect and mixed treatment outcomes) • Matching-adjusted indirect comparisons (MAIC) • Survival analysis for economic modelling • Independent review of published HTA reports Ecotoxicology • All OECD standard tests to GLP In addition to biostatistics consultancy, we provide an commercial software package called QuBAS, which has been developed specifically for bioassay/ELISA relative potency and interpolation analysis. QuBAS is currently being used globally, helping both Big Pharma and niche companies better understand their assays in order to successfully advance their therapies. We offer a 365 day service and fast project turnaround. Our team are multilingual (French, German, Italian & more). Explore our website for more detail on our services including QuBAS, and see how we can help you get your product to market.